Stay tuned
Lowering FDA fees would spur generics manufacturing in US, Mark Cuban says
Mark Cuban, the co-founder of online pharmacy Cost Plus Drugs, says h
ASH: Pfizer, aiming to level the hemophilia playing field, trots out new Hympavzi data
Pfizer has unveiled phase 3 results that could help the company’s h
CDC's ACIP votes to change long-standing hepatitis B vaccine guidance for newborns, prompting backlash
The CDC's vaccine advisory committee voted 8-2 in favor of an individ
'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out
The industry’s mRNA alliance is demanding steady FDA leadership, wa
AbbVie revs up Skyrizi spending to top TV ad totals in November, edging out J&J’s Tremfya
After a record-setting October that easily dwarfed all preceding mont
Stay tuned
© 1994 - 2025 B.M. Pharmaceuticals